Table of Contents Executive Summary 1 Industry Overview of Recombinant Therapeutic Antibodies and Proteins 1.1 Definition of Recombinant Therapeutic Antibodies and Proteins 1.2 Recombinant Therapeutic Antibodies and Proteins Segment by Type 1.2.1 Global Recombinant Therapeutic Antibodies and Proteins Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Plasma Protein 1.2.3 Fusion Proteins 1.2.4 Monoclonal Antibodies 1.2.5 Hormones 1.2.6 Enzyme 1.2.7 Coagulation Factors 1.2.8 Others 1.3 Recombinant Therapeutic Antibodies and Proteins Segment by Applications 1.3.1 Global Recombinant Therapeutic Antibodies and Proteins Consumption Comparison by Applications (2014-2025) 1.3.2 Oncology 1.3.3 Hematology 1.3.4 Immunology 1.3.5 Endocrinology 1.3.6 Infectious Disease 1.3.7 Cardiovascular Disease 1.3.8 Others 1.4 Global Recombinant Therapeutic Antibodies and Proteins Overall Market 1.4.1 Global Recombinant Therapeutic Antibodies and Proteins Revenue (2014-2025) 1.4.2 Global Recombinant Therapeutic Antibodies and Proteins Production (2014-2025) 1.4.3 North America Recombinant Therapeutic Antibodies and Proteins Status and Prospect (2014-2025) 1.4.4 Europe Recombinant Therapeutic Antibodies and Proteins Status and Prospect (2014-2025) 1.4.5 China Recombinant Therapeutic Antibodies and Proteins Status and Prospect (2014-2025) 1.4.6 Japan Recombinant Therapeutic Antibodies and Proteins Status and Prospect (2014-2025) 1.4.7 Southeast Asia Recombinant Therapeutic Antibodies and Proteins Status and Prospect (2014-2025) 1.4.8 India Recombinant Therapeutic Antibodies and Proteins Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Recombinant Therapeutic Antibodies and Proteins 2.3 Manufacturing Process Analysis of Recombinant Therapeutic Antibodies and Proteins 2.4 Industry Chain Structure of Recombinant Therapeutic Antibodies and Proteins 3 Development and Manufacturing Plants Analysis of Recombinant Therapeutic Antibodies and Proteins 3.1 Capacity and Commercial Production Date 3.2 Global Recombinant Therapeutic Antibodies and Proteins Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Recombinant Therapeutic Antibodies and Proteins 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Recombinant Therapeutic Antibodies and Proteins Production and Capacity Analysis 4.2 Recombinant Therapeutic Antibodies and Proteins Revenue Analysis 4.3 Recombinant Therapeutic Antibodies and Proteins Price Analysis 4.4 Market Concentration Degree 5 Recombinant Therapeutic Antibodies and Proteins Regional Market Analysis 5.1 Recombinant Therapeutic Antibodies and Proteins Production by Regions 5.1.1 Global Recombinant Therapeutic Antibodies and Proteins Production by Regions 5.1.2 Global Recombinant Therapeutic Antibodies and Proteins Revenue by Regions 5.2 Recombinant Therapeutic Antibodies and Proteins Consumption by Regions 5.3 North America Recombinant Therapeutic Antibodies and Proteins Market Analysis 5.3.1 North America Recombinant Therapeutic Antibodies and Proteins Production 5.3.2 North America Recombinant Therapeutic Antibodies and Proteins Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Recombinant Therapeutic Antibodies and Proteins Import and Export 5.4 Europe Recombinant Therapeutic Antibodies and Proteins Market Analysis 5.4.1 Europe Recombinant Therapeutic Antibodies and Proteins Production 5.4.2 Europe Recombinant Therapeutic Antibodies and Proteins Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Recombinant Therapeutic Antibodies and Proteins Import and Export 5.5 China Recombinant Therapeutic Antibodies and Proteins Market Analysis 5.5.1 China Recombinant Therapeutic Antibodies and Proteins Production 5.5.2 China Recombinant Therapeutic Antibodies and Proteins Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Recombinant Therapeutic Antibodies and Proteins Import and Export 5.6 Japan Recombinant Therapeutic Antibodies and Proteins Market Analysis 5.6.1 Japan Recombinant Therapeutic Antibodies and Proteins Production 5.6.2 Japan Recombinant Therapeutic Antibodies and Proteins Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Recombinant Therapeutic Antibodies and Proteins Import and Export 5.7 Southeast Asia Recombinant Therapeutic Antibodies and Proteins Market Analysis 5.7.1 Southeast Asia Recombinant Therapeutic Antibodies and Proteins Production 5.7.2 Southeast Asia Recombinant Therapeutic Antibodies and Proteins Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Recombinant Therapeutic Antibodies and Proteins Import and Export 5.8 India Recombinant Therapeutic Antibodies and Proteins Market Analysis 5.8.1 India Recombinant Therapeutic Antibodies and Proteins Production 5.8.2 India Recombinant Therapeutic Antibodies and Proteins Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Recombinant Therapeutic Antibodies and Proteins Import and Export 6 Recombinant Therapeutic Antibodies and Proteins Segment Market Analysis (by Type) 6.1 Global Recombinant Therapeutic Antibodies and Proteins Production by Type 6.2 Global Recombinant Therapeutic Antibodies and Proteins Revenue by Type 6.3 Recombinant Therapeutic Antibodies and Proteins Price by Type 7 Recombinant Therapeutic Antibodies and Proteins Segment Market Analysis (by Application) 7.1 Global Recombinant Therapeutic Antibodies and Proteins Consumption by Application 7.2 Global Recombinant Therapeutic Antibodies and Proteins Consumption Market Share by Application (2014-2019) 8 Recombinant Therapeutic Antibodies and Proteins Major Manufacturers Analysis 8.1 Abbott 8.1.1 Abbott Recombinant Therapeutic Antibodies and Proteins Production Sites and Area Served 8.1.2 Abbott Product Introduction, Application and Specification 8.1.3 Abbott Recombinant Therapeutic Antibodies and Proteins Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Amgen 8.2.1 Amgen Recombinant Therapeutic Antibodies and Proteins Production Sites and Area Served 8.2.2 Amgen Product Introduction, Application and Specification 8.2.3 Amgen Recombinant Therapeutic Antibodies and Proteins Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 Biogen 8.3.1 Biogen Recombinant Therapeutic Antibodies and Proteins Production Sites and Area Served 8.3.2 Biogen Product Introduction, Application and Specification 8.3.3 Biogen Recombinant Therapeutic Antibodies and Proteins Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Eli Lilly 8.4.1 Eli Lilly Recombinant Therapeutic Antibodies and Proteins Production Sites and Area Served 8.4.2 Eli Lilly Product Introduction, Application and Specification 8.4.3 Eli Lilly Recombinant Therapeutic Antibodies and Proteins Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 Roche 8.5.1 Roche Recombinant Therapeutic Antibodies and Proteins Production Sites and Area Served 8.5.2 Roche Product Introduction, Application and Specification 8.5.3 Roche Recombinant Therapeutic Antibodies and Proteins Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 8.6 Johnson and Johnson 8.6.1 Johnson and Johnson Recombinant Therapeutic Antibodies and Proteins Production Sites and Area Served 8.6.2 Johnson and Johnson Product Introduction, Application and Specification 8.6.3 Johnson and Johnson Recombinant Therapeutic Antibodies and Proteins Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.6.4 Main Business and Markets Served 8.7 Merck 8.7.1 Merck Recombinant Therapeutic Antibodies and Proteins Production Sites and Area Served 8.7.2 Merck Product Introduction, Application and Specification 8.7.3 Merck Recombinant Therapeutic Antibodies and Proteins Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.7.4 Main Business and Markets Served 8.8 Novo Nordisk 8.8.1 Novo Nordisk Recombinant Therapeutic Antibodies and Proteins Production Sites and Area Served 8.8.2 Novo Nordisk Product Introduction, Application and Specification 8.8.3 Novo Nordisk Recombinant Therapeutic Antibodies and Proteins Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.8.4 Main Business and Markets Served 8.9 Pfizer 8.9.1 Pfizer Recombinant Therapeutic Antibodies and Proteins Production Sites and Area Served 8.9.2 Pfizer Product Introduction, Application and Specification 8.9.3 Pfizer Recombinant Therapeutic Antibodies and Proteins Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.9.4 Main Business and Markets Served 8.10 Sanofi 8.10.1 Sanofi Recombinant Therapeutic Antibodies and Proteins Production Sites and Area Served 8.10.2 Sanofi Product Introduction, Application and Specification 8.10.3 Sanofi Recombinant Therapeutic Antibodies and Proteins Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.10.4 Main Business and Markets Served 9 Development Trend of Analysis of Recombinant Therapeutic Antibodies and Proteins Market 9.1 Global Recombinant Therapeutic Antibodies and Proteins Market Trend Analysis 9.1.1 Global Recombinant Therapeutic Antibodies and Proteins Market Size (Volume and Value) Forecast 2019-2025 9.2 Recombinant Therapeutic Antibodies and Proteins Regional Market Trend 9.2.1 North America Recombinant Therapeutic Antibodies and Proteins Forecast 2019-2025 9.2.2 Europe Recombinant Therapeutic Antibodies and Proteins Forecast 2019-2025 9.2.3 China Recombinant Therapeutic Antibodies and Proteins Forecast 2019-2025 9.2.4 Japan Recombinant Therapeutic Antibodies and Proteins Forecast 2019-2025 9.2.5 Southeast Asia Recombinant Therapeutic Antibodies and Proteins Forecast 2019-2025 9.2.6 India Recombinant Therapeutic Antibodies and Proteins Forecast 2019-2025 9.3 Recombinant Therapeutic Antibodies and Proteins Market Trend (Product Type) 9.4 Recombinant Therapeutic Antibodies and Proteins Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Recombinant Therapeutic Antibodies and Proteins Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Recombinant Therapeutic Antibodies and Proteins Table Global Recombinant Therapeutic Antibodies and Proteins Production (K Units) Growth Rate Comparison by Types (2014-2025) Figure Global Recombinant Therapeutic Antibodies and Proteins Production Market Share by Types in 2018 Figure Plasma Protein Product Picture Figure Fusion Proteins Product Picture Figure Monoclonal Antibodies Product Picture Figure Hormones Product Picture Figure Enzyme Product Picture Figure Coagulation Factors Product Picture Figure Others Product Picture Table Global Recombinant Therapeutic Antibodies and Proteins Consumption (K Units) Comparison by Applications (2014-2025) Figure Global Recombinant Therapeutic Antibodies and Proteins Consumption Market Share by Applications in 2018 Figure Oncology Figure Hematology Figure Immunology Figure Endocrinology Figure Infectious Disease Figure Cardiovascular Disease Figure Others Figure Global Recombinant Therapeutic Antibodies and Proteins Revenue (Million USD) (2014-2025) Figure Global Recombinant Therapeutic Antibodies and Proteins Production (K Units) (2014-2025) Figure North America Recombinant Therapeutic Antibodies and Proteins Market Size (Million USD) (2014-2025) Figure Europe Recombinant Therapeutic Antibodies and Proteins Market Size (Million USD) (2014-2025) Figure China Recombinant Therapeutic Antibodies and Proteins Market Size (Million USD) (2014-2025) Figure Japan Recombinant Therapeutic Antibodies and Proteins Market Size (Million USD) (2014-2025) Figure Southeast Asia Recombinant Therapeutic Antibodies and Proteins Market Size (Million USD) (2014-2025) Figure India Recombinant Therapeutic Antibodies and Proteins Market Size (Million USD) (2014-2025) Table Recombinant Therapeutic Antibodies and Proteins Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Recombinant Therapeutic Antibodies and Proteins in 2018 Figure Manufacturing Process Analysis of Recombinant Therapeutic Antibodies and Proteins Figure Industry Chain Structure of Recombinant Therapeutic Antibodies and Proteins Table Capacity and Commercial Production Date of Key Manufacturers Table Global Recombinant Therapeutic Antibodies and Proteins Manufacturing Plants Distribution Table Recombinant Therapeutic Antibodies and Proteins Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Recombinant Therapeutic Antibodies and Proteins Capacity (K Units) of Major Manufacturers (2014-2019) Table Recombinant Therapeutic Antibodies and Proteins Production (K Units) of Major Manufacturers (2014-2019) Table Recombinant Therapeutic Antibodies and Proteins Production Market Share of Major Manufacturers (2014-2019) Figure Recombinant Therapeutic Antibodies and Proteins Production Share by Manufacturers in 2018 Table Recombinant Therapeutic Antibodies and Proteins Revenue (Million US$) of Major Manufacturers (2014-2019) Table Recombinant Therapeutic Antibodies and Proteins Revenue Market Share of Major Manufacturers (2014-2019) Figure Recombinant Therapeutic Antibodies and Proteins Revenue Share by Manufacturers in 2018 Table Recombinant Therapeutic Antibodies and Proteins Average Price (USD/Unit) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Recombinant Therapeutic Antibodies and Proteins Production by Regions 2014-2019 (K Units) Table Global Recombinant Therapeutic Antibodies and Proteins Production Market Share by Regions 2014-2019 Figure Global Recombinant Therapeutic Antibodies and Proteins Production Market Share by Regions in 2018 Table Global Recombinant Therapeutic Antibodies and Proteins Revenue by Regions 2014-2019 (Million USD) Table Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Regions 2014-2019 Figure Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Regions in 2018 Table Global Recombinant Therapeutic Antibodies and Proteins Consumption by Regions 2014-2019 (K Units) Table Global Recombinant Therapeutic Antibodies and Proteins Consumption Market Share by Regions 2014-2019 Figure North America Recombinant Therapeutic Antibodies and Proteins Production Growth Rate 2014-2019 (K Units) Figure North America Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate 2014-2019 (Million USD) Table North America Recombinant Therapeutic Antibodies and Proteins Production, Consumption Import and Export (K Units) Figure Europe Recombinant Therapeutic Antibodies and Proteins Production Growth Rate 2014-2019 (K Units) Figure Europe Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate 2014-2019 (Million USD) Table Europe Recombinant Therapeutic Antibodies and Proteins Production, Consumption Import and Export (K Units) Figure China Recombinant Therapeutic Antibodies and Proteins Production Growth Rate 2014-2019 (K Units) Figure China Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate 2014-2019 (Million USD) Table China Recombinant Therapeutic Antibodies and Proteins Production, Consumption Import and Export (K Units) Figure Japan Recombinant Therapeutic Antibodies and Proteins Production Growth Rate 2014-2019 (K Units) Figure Japan Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate 2014-2019 (Million USD) Table Japan Recombinant Therapeutic Antibodies and Proteins Production, Consumption Import and Export (K Units) Figure Southeast Asia Recombinant Therapeutic Antibodies and Proteins Production Growth Rate 2014-2019 (K Units) Figure Southeast Asia Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Recombinant Therapeutic Antibodies and Proteins Production, Consumption Import and Export (K Units) Figure India Recombinant Therapeutic Antibodies and Proteins Production Growth Rate 2014-2019 (K Units) Figure India Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate 2014-2019 (Million USD) Table India Recombinant Therapeutic Antibodies and Proteins Production, Consumption Import and Export (K Units) Figure Global Consumption Recombinant Therapeutic Antibodies and Proteins Market Share by Application (2014-2019) Figure Global Value (Consumption) Recombinant Therapeutic Antibodies and Proteins Market Share by Application (2014-2019) Table Abbott Recombinant Therapeutic Antibodies and Proteins Production Sites and Area Served Table Abbott Recombinant Therapeutic Antibodies and Proteins Product Introduction, Application and Specification Table Abbott Recombinant Therapeutic Antibodies and Proteins Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Abbott Recombinant Therapeutic Antibodies and Proteins Production Growth Rate (2014-2019) Table Abbott Recombinant Therapeutic Antibodies and Proteins Production Market Share (2014-2019) Figure Abbott Recombinant Therapeutic Antibodies and Proteins Revenue Market Share (2014-2019) Table Abbott Recombinant Therapeutic Antibodies and Proteins Main Business and Markets Served Table Amgen Recombinant Therapeutic Antibodies and Proteins Production Sites and Area Served Table Amgen Recombinant Therapeutic Antibodies and Proteins Product Introduction, Application and Specification Table Amgen Recombinant Therapeutic Antibodies and Proteins Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Amgen Recombinant Therapeutic Antibodies and Proteins Production Growth Rate (2014-2019) Table Amgen Recombinant Therapeutic Antibodies and Proteins Production Market Share (2014-2019) Figure Amgen Recombinant Therapeutic Antibodies and Proteins Revenue Market Share (2014-2019) Table Amgen Recombinant Therapeutic Antibodies and Proteins Main Business and Markets Served Table Biogen Recombinant Therapeutic Antibodies and Proteins Production Sites and Area Served Table Biogen Recombinant Therapeutic Antibodies and Proteins Product Introduction, Application and Specification Table Biogen Recombinant Therapeutic Antibodies and Proteins Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Biogen Recombinant Therapeutic Antibodies and Proteins Production Growth Rate (2014-2019) Table Biogen Recombinant Therapeutic Antibodies and Proteins Production Market Share (2014-2019) Figure Biogen Recombinant Therapeutic Antibodies and Proteins Revenue Market Share (2014-2019) Table Biogen Recombinant Therapeutic Antibodies and Proteins Main Business and Markets Served Table Eli Lilly Recombinant Therapeutic Antibodies and Proteins Production Sites and Area Served Table Eli Lilly Recombinant Therapeutic Antibodies and Proteins Product Introduction, Application and Specification Table Eli Lilly Recombinant Therapeutic Antibodies and Proteins Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Eli Lilly Recombinant Therapeutic Antibodies and Proteins Production Growth Rate (2014-2019) Table Eli Lilly Recombinant Therapeutic Antibodies and Proteins Production Market Share (2014-2019) Figure Eli Lilly Recombinant Therapeutic Antibodies and Proteins Revenue Market Share (2014-2019) Table Eli Lilly Recombinant Therapeutic Antibodies and Proteins Main Business and Markets Served Table Roche Recombinant Therapeutic Antibodies and Proteins Production Sites and Area Served Table Roche Recombinant Therapeutic Antibodies and Proteins Product Introduction, Application and Specification Table Roche Recombinant Therapeutic Antibodies and Proteins Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Roche Recombinant Therapeutic Antibodies and Proteins Production Growth Rate (2014-2019) Table Roche Recombinant Therapeutic Antibodies and Proteins Production Market Share (2014-2019) Figure Roche Recombinant Therapeutic Antibodies and Proteins Revenue Market Share (2014-2019) Table Roche Recombinant Therapeutic Antibodies and Proteins Main Business and Markets Served Table Johnson and Johnson Recombinant Therapeutic Antibodies and Proteins Production Sites and Area Served Table Johnson and Johnson Recombinant Therapeutic Antibodies and Proteins Product Introduction, Application and Specification Table Johnson and Johnson Recombinant Therapeutic Antibodies and Proteins Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Johnson and Johnson Recombinant Therapeutic Antibodies and Proteins Production Growth Rate (2014-2019) Table Johnson and Johnson Recombinant Therapeutic Antibodies and Proteins Production Market Share (2014-2019) Figure Johnson and Johnson Recombinant Therapeutic Antibodies and Proteins Revenue Market Share (2014-2019) Table Johnson and Johnson Recombinant Therapeutic Antibodies and Proteins Main Business and Markets Served Table Merck Recombinant Therapeutic Antibodies and Proteins Production Sites and Area Served Table Merck Recombinant Therapeutic Antibodies and Proteins Product Introduction, Application and Specification Table Merck Recombinant Therapeutic Antibodies and Proteins Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Merck Recombinant Therapeutic Antibodies and Proteins Production Growth Rate (2014-2019) Table Merck Recombinant Therapeutic Antibodies and Proteins Production Market Share (2014-2019) Figure Merck Recombinant Therapeutic Antibodies and Proteins Revenue Market Share (2014-2019) Table Merck Recombinant Therapeutic Antibodies and Proteins Main Business and Markets Served Table Novo Nordisk Recombinant Therapeutic Antibodies and Proteins Production Sites and Area Served Table Novo Nordisk Recombinant Therapeutic Antibodies and Proteins Product Introduction, Application and Specification Table Novo Nordisk Recombinant Therapeutic Antibodies and Proteins Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Novo Nordisk Recombinant Therapeutic Antibodies and Proteins Production Growth Rate (2014-2019) Table Novo Nordisk Recombinant Therapeutic Antibodies and Proteins Production Market Share (2014-2019) Figure Novo Nordisk Recombinant Therapeutic Antibodies and Proteins Revenue Market Share (2014-2019) Table Novo Nordisk Recombinant Therapeutic Antibodies and Proteins Main Business and Markets Served Table Pfizer Recombinant Therapeutic Antibodies and Proteins Production Sites and Area Served Table Pfizer Recombinant Therapeutic Antibodies and Proteins Product Introduction, Application and Specification Table Pfizer Recombinant Therapeutic Antibodies and Proteins Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Pfizer Recombinant Therapeutic Antibodies and Proteins Production Growth Rate (2014-2019) Table Pfizer Recombinant Therapeutic Antibodies and Proteins Production Market Share (2014-2019) Figure Pfizer Recombinant Therapeutic Antibodies and Proteins Revenue Market Share (2014-2019) Table Pfizer Recombinant Therapeutic Antibodies and Proteins Main Business and Markets Served Table Sanofi Recombinant Therapeutic Antibodies and Proteins Production Sites and Area Served Table Sanofi Recombinant Therapeutic Antibodies and Proteins Product Introduction, Application and Specification Table Sanofi Recombinant Therapeutic Antibodies and Proteins Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Sanofi Recombinant Therapeutic Antibodies and Proteins Production Growth Rate (2014-2019) Table Sanofi Recombinant Therapeutic Antibodies and Proteins Production Market Share (2014-2019) Figure Sanofi Recombinant Therapeutic Antibodies and Proteins Revenue Market Share (2014-2019) Table Sanofi Recombinant Therapeutic Antibodies and Proteins Main Business and Markets Served Figure Global Recombinant Therapeutic Antibodies and Proteins Production (K Units) Growth Rate Forecast 2019-2025 Figure Global Recombinant Therapeutic Antibodies and Proteins Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Recombinant Therapeutic Antibodies and Proteins Sales Price (USD/Unit) Forecast 2019-2025 Figure North America Recombinant Therapeutic Antibodies and Proteins Production Growth Rate Forecast 2019-2025 (K Units) Figure North America Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Recombinant Therapeutic Antibodies and Proteins Production Growth Rate Forecast 2019-2025 (K Units) Figure Europe Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Recombinant Therapeutic Antibodies and Proteins Production Growth Rate Forecast 2019-2025 (K Units) Figure China Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Recombinant Therapeutic Antibodies and Proteins Production Growth Rate Forecast 2019-2025 (K Units) Figure Japan Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Recombinant Therapeutic Antibodies and Proteins Production Growth Rate Forecast 2019-2025 (K Units) Figure Southeast Asia Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Recombinant Therapeutic Antibodies and Proteins Production Growth Rate Forecast 2019-2025 (K Units) Figure India Recombinant Therapeutic Antibodies and Proteins Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Units) of Recombinant Therapeutic Antibodies and Proteins by Type (2019-2025) Table Global Consumption (K Units) of Recombinant Therapeutic Antibodies and Proteins by Application (2019-2025) Table Recombinant Therapeutic Antibodies and Proteins Distributors List Table Recombinant Therapeutic Antibodies and Proteins Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Abbott Amgen Biogen Eli Lilly Roche Johnson and Johnson Merck Novo Nordisk Pfizer Sanofi